Khiron Life Sciences Corp.
Rank 62
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
$1.1010
USD
2.84%
Market cap
$125,432,164
Total volume
$395,980
Shares outstanding
113,927,120
Rank 62
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
KHRN |
$317,286
|
80.13% |
$1.1010
|
| KHRNF |
Total volume
$78,694
|
19.87% |
Stock price
$1.1000
|
Chart